<p>美國股市近期表現不一，漲幅受到持續的關税不確定性和各公司財報差異的影響。對於願意探索知名公司之外的投資者來説，便士股——通常與較小或較新的公司相關——仍然可以提供有趣的機會。儘管這個術語有些過時，但這些股票依然相關，因為在強勁的資產負債表和穩健的基本面支持下，它們在較低價格點上展現出增長潛力。</p>
<h3>美國十大便士股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.36</td>
<td>$3.4913 億</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.25</td>
<td>$13 億</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.06</td>
<td>$1848 萬</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.20</td>
<td>$936 萬</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.829</td>
<td>$4819 萬</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>TETRA Technologies (NYSE:TTI)</td>
<td>$2.62</td>
<td>$3.2701 億</td>
<td>✅ 5 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8099</td>
<td>$581 萬</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>QuantaSing Group (NasdaqGM:QSG)</td>
<td>$3.08</td>
<td>$2.6374 億</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.71</td>
<td>$8245 萬</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.74</td>
<td>$6530 萬</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們美國便士股篩選器的 761 只股票完整列表。</p>
<p>以下是篩選器中的一些選擇。</p>
<h2>QuantaSing Group (NasdaqGM:QSG)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> QuantaSing Group Limited 在中國提供在線學習服務，市值約為 2.6374 億美元。</p>
<p><strong>運營：</strong> 該公司在中國的運營收入為 34.8 億人民幣。</p>
<p><strong>市值：</strong> $2.6374 億</p>
<p>QuantaSing Group Limited 市值為 2.6374 億美元，專注於中國的在線學習領域，顯示出顯著的盈利增長，過去一年盈利增長 107.7%。儘管其股價波動較大且董事會經驗不足，但 QuantaSing 的交易價格大幅低於其估計的公允價值，並保持強勁的財務健康，零債務且充足的短期資產覆蓋負債。該公司在最近六個月報告銷售額為 15.4 億人民幣，但預計未來三年盈利將下降。</p>
<ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 QuantaSing Group 的動態。</li>
<li>通過查看我們的增長報告，獲取對 QuantaSing Group 未來方向的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 4 月的 NasdaqGM:QSG 收入與支出細分</p>
<h2>Gossamer Bio (NasdaqGS:GOSS)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Gossamer Bio, Inc. 是一家臨牀階段的生物製藥公司，致力於開發和商業化用於治療美國肺動脈高壓的 seralutinib，市值為 2.0332 億美元。</p>
<p><strong>運營：</strong> 該公司的收入主要來自其製藥部門，總計 1.147 億美金。</p>
<p><strong>市值：</strong> $2.0332 億</p>
<p>Gossamer Bio, Inc. 市值為 2.0332 億美元，專注於開發肺動脈高壓的治療方案。儘管目前尚未盈利，且預計在未來三年內不會實現盈利，但 Gossamer 在過去五年中每年減少了 12.8% 的虧損。其短期資產為 3.099 億美元，超過短期和長期負債，表明相對於債務義務的強勁財務健康。最近的盈利顯示，淨虧損從 1.7982 億美元減少到 5653 萬美元，2024 年收入達到 1.147 億美元，反映出在股價高度波動中持續的運營進展。</p>
<ul>
<li>通過我們的綜合資產負債表健康報告深入瞭解 Gossamer Bio 的複雜性。</li>
<li>通過我們的詳細增長報告評估 Gossamer Bio 未來的盈利預期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 4 月的 NasdaqGS:GOSS 債務與股本歷史及分析</p>
<h2>Vista Gold (NYSEAM:VGZ)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Vista Gold Corp.及其子公司是一家專注於澳大利亞黃金礦業的開發階段公司，市值約為 1.179 億美元。</p>
<p><strong>運營：</strong> Vista Gold Corp. 目前沒有報告任何收入細分。</p>
<p><strong>市值：</strong> $1.179 億</p>
<p>Vista Gold Corp. 市值約為 1.179 億美元，已轉向盈利，2024 年報告淨收入 1125 萬美元，而前一年為淨虧損。公司的股本回報率高達 62.8%，且保持無債務，周波動穩定。儘管尚未產生收入，Vista Gold 的潛力因其在澳大利亞 Mt Todd 項目的有希望的鑽探結果而增強，這可能增加黃金礦藏儲量並改善未來前景。經驗豐富的管理層和董事會進一步增強了其在競爭激烈的礦業領域的地位。</p>
<ul>
<li>解鎖我們對 Vista Gold 股票分析的全面見解，查看此財務健康報告。</li>
<li>檢查 Vista Gold 的過往業績報告，以瞭解其在過去幾年的表現。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis"/></p>
<p>截至 2025 年 4 月的 NYSEAM:VGZ 財務狀況分析</p>
<h2>利用機會</h2>
<ul>
<li>深入瞭解我們在這裏識別的 761 只美國便士股票。</li>
<li>對其他可能性感興趣？今天最好的人工智能股票可能不止於像 Nvidia 和 Microsoft 這樣的巨頭。通過這 24 家專注於人工智能的小型公司，尋找下一個重大機會，這些公司在機器學習、自動化和數據智能方面的早期創新具有強大的增長潛力，可能為您的退休提供資金。</li>
</ul>
<p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，僅使用無偏見的方法，我們的文章不構成財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<p>如果您想交易 QuantaSing Group，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
<p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
<p>享受無隱藏費用，無賬户最低限額，外匯轉換率低至 0.03%，遠遠優於大多數經紀商提供的服務。</p>
<p>贊助內容</p>

GOSS

量子之歌

Vista黃金

HERE

<p>這篇文章討論了三隻前景看好的低價股，市值均超過 1 億美元：量子之歌（QuantaSing Group）、Gossamer Bio 和 Vista 黃金（Vista Gold）。量子之歌的市值為 2.6374 億美元，專注於中國的在線學習，並顯示出顯著的盈利增長。Gossamer Bio 的市值為 2.0332 億美元，專注於治療肺動脈高壓，但仍處於虧損狀態。Vista 黃金的市值為 1.1790 億美元，是一家位於澳大利亞的開發階段黃金礦業公司，最近已轉向盈利。文章強調了在持續的市場不確定性中，這些股票的潛力</p>

<p>Stocks in the United States have been mixed recently, with gains tempered by ongoing tariff uncertainties and varying corporate earnings reports. For investors willing to explore beyond the well-known names, penny stocks—often associated with smaller or newer companies—can still offer intriguing opportunities. Despite being a somewhat outdated term, these stocks remain relevant as they present potential for growth at lower price points when supported by strong balance sheets and solid fundamentals.</p>
<div class="lb-trans"><p>美國股市近期表現不一，漲幅受到持續的關税不確定性和各公司財報差異的影響。對於願意探索知名公司之外的投資者來説，便士股——通常與較小或較新的公司相關——仍然可以提供有趣的機會。儘管這個術語有些過時，但這些股票依然相關，因為在強勁的資產負債表和穩健的基本面支持下，它們在較低價格點上展現出增長潛力。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美國十大便士股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.36</td>
<td>$349.13M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.25</td>
<td>$1.3B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.06</td>
<td>$18.48M</td>
<td>✅ 4 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.20</td>
<td>$9.36M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.829</td>
<td>$48.19M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>TETRA Technologies (NYSE:TTI)</td>
<td>$2.62</td>
<td>$327.01M</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8099</td>
<td>$5.81M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>QuantaSing Group (NasdaqGM:QSG)</td>
<td>$3.08</td>
<td>$263.74M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.71</td>
<td>$82.45M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.74</td>
<td>$65.3M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.36</td>
<td>$3.4913 億</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.25</td>
<td>$13 億</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.06</td>
<td>$1848 萬</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.20</td>
<td>$936 萬</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.829</td>
<td>$4819 萬</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>TETRA Technologies (NYSE:TTI)</td>
<td>$2.62</td>
<td>$3.2701 億</td>
<td>✅ 5 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8099</td>
<td>$581 萬</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>QuantaSing Group (NasdaqGM:QSG)</td>
<td>$3.08</td>
<td>$2.6374 億</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.71</td>
<td>$8245 萬</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.74</td>
<td>$6530 萬</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 761 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們美國便士股篩選器的 761 只股票完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是篩選器中的一些選擇。</p>
</div><h2>QuantaSing Group (NasdaqGM:QSG)</h2>
<div class="lb-trans"><h2>QuantaSing Group (NasdaqGM:QSG)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> QuantaSing Group Limited offers online learning services in the People’s Republic of China and has a market capitalization of approximately $263.74 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> QuantaSing Group Limited 在中國提供在線學習服務，市值約為 2.6374 億美元。</p>
</div><p><strong>Operations:</strong> The company generates its revenue of CN¥3.48 billion from operations within the People's Republic of China.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司在中國的運營收入為 34.8 億人民幣。</p>
</div><p><strong>Market Cap:</strong> $263.74M</p>
<div class="lb-trans"><p><strong>市值：</strong> $2.6374 億</p>
</div><p>QuantaSing Group Limited, with a market cap of US$263.74 million, operates in the online learning sector in China and has shown significant profitability growth, achieving a 107.7% increase in earnings over the past year. Despite its volatile share price and inexperienced board, QuantaSing trades at a substantial discount to its estimated fair value and maintains strong financial health with no debt and ample short-term assets covering liabilities. The company reported CN¥1.54 billion in sales for the recent six months but faces forecasted earnings declines over the next three years.</p>
<div class="lb-trans"><p>QuantaSing Group Limited 市值為 2.6374 億美元，專注於中國的在線學習領域，顯示出顯著的盈利增長，過去一年盈利增長 107.7%。儘管其股價波動較大且董事會經驗不足，但 QuantaSing 的交易價格大幅低於其估計的公允價值，並保持強勁的財務健康，零債務且充足的短期資產覆蓋負債。該公司在最近六個月報告銷售額為 15.4 億人民幣，但預計未來三年盈利將下降。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of QuantaSing Group.</li>
<li>Gain insights into QuantaSing Group's future direction by reviewing our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們的完整財務健康分析報告，以瞭解 QuantaSing Group 的動態。</li>
<li>通過查看我們的增長報告，獲取對 QuantaSing Group 未來方向的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/95f4d8eb-3935-418d-9447-ab4d6ce40792/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:QSG Revenue &amp; Expenses Breakdown as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 NasdaqGM:QSG 收入與支出細分</p>
</div><h2>Gossamer Bio (NasdaqGS:GOSS)</h2>
<div class="lb-trans"><h2>Gossamer Bio (NasdaqGS:GOSS)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for treating pulmonary arterial hypertension in the United States, with a market cap of $203.32 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Gossamer Bio, Inc. 是一家臨牀階段的生物製藥公司，致力於開發和商業化用於治療美國肺動脈高壓的 seralutinib，市值為 2.0332 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from its Pharmaceuticals segment, totaling $114.70 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自其製藥部門，總計 1.147 億美金。</p>
</div><p><strong>Market Cap:</strong> $203.32M</p>
<div class="lb-trans"><p><strong>市值：</strong> $2.0332 億</p>
</div><p>Gossamer Bio, Inc., with a market cap of US$203.32 million, is focused on developing treatments for pulmonary arterial hypertension. Despite being unprofitable and not expected to achieve profitability in the next three years, Gossamer has reduced its losses by 12.8% annually over the past five years. Its short-term assets of US$309.9 million exceed both short and long-term liabilities, indicating strong financial health relative to debt obligations. Recent earnings show a net loss reduction from US$179.82 million to US$56.53 million year-over-year, while revenue reached US$114.7 million in 2024, reflecting ongoing operational progress amidst high share price volatility.</p>
<div class="lb-trans"><p>Gossamer Bio, Inc. 市值為 2.0332 億美元，專注於開發肺動脈高壓的治療方案。儘管目前尚未盈利，且預計在未來三年內不會實現盈利，但 Gossamer 在過去五年中每年減少了 12.8% 的虧損。其短期資產為 3.099 億美元，超過短期和長期負債，表明相對於債務義務的強勁財務健康。最近的盈利顯示，淨虧損從 1.7982 億美元減少到 5653 萬美元，2024 年收入達到 1.147 億美元，反映出在股價高度波動中持續的運營進展。</p>
</div><ul>
<li>Navigate through the intricacies of Gossamer Bio with our comprehensive balance sheet health report here.</li>
<li>Assess Gossamer Bio's future earnings estimates with our detailed growth reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的綜合資產負債表健康報告深入瞭解 Gossamer Bio 的複雜性。</li>
<li>通過我們的詳細增長報告評估 Gossamer Bio 未來的盈利預期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/0e7368f8-d1cb-4760-b556-aa2d18778279/chart/debt-equity-history-analysis"/></p>
<p>NasdaqGS:GOSS Debt to Equity History and Analysis as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 NasdaqGS:GOSS 債務與股本歷史及分析</p>
</div><h2>Vista Gold (NYSEAM:VGZ)</h2>
<div class="lb-trans"><h2>Vista Gold (NYSEAM:VGZ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Vista Gold Corp., along with its subsidiaries, is a development-stage company focused on the gold mining industry in Australia, with a market cap of approximately $117.90 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Vista Gold Corp.及其子公司是一家專注於澳大利亞黃金礦業的開發階段公司，市值約為 1.179 億美元。</p>
</div><p><strong>Operations:</strong> Vista Gold Corp. does not report any revenue segments at this time.</p>
<div class="lb-trans"><p><strong>運營：</strong> Vista Gold Corp. 目前沒有報告任何收入細分。</p>
</div><p><strong>Market Cap:</strong> $117.9M</p>
<div class="lb-trans"><p><strong>市值：</strong> $1.179 億</p>
</div><p>Vista Gold Corp., with a market cap of approximately US$117.90 million, has transitioned to profitability, reporting a net income of US$11.25 million for 2024 compared to a net loss the previous year. The company's return on equity is outstanding at 62.8%, and it remains debt-free with stable weekly volatility. Despite being pre-revenue, Vista Gold's potential is bolstered by promising drilling results at its Mt Todd project in Australia, which could increase gold mineral reserves and enhance future prospects. The seasoned management and board further strengthen its position in the competitive mining sector.</p>
<div class="lb-trans"><p>Vista Gold Corp. 市值約為 1.179 億美元，已轉向盈利，2024 年報告淨收入 1125 萬美元，而前一年為淨虧損。公司的股本回報率高達 62.8%，且保持無債務，周波動穩定。儘管尚未產生收入，Vista Gold 的潛力因其在澳大利亞 Mt Todd 項目的有希望的鑽探結果而增強，這可能增加黃金礦藏儲量並改善未來前景。經驗豐富的管理層和董事會進一步增強了其在競爭激烈的礦業領域的地位。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Vista Gold stock in this financial health report.</li>
<li>Examine Vista Gold's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖我們對 Vista Gold 股票分析的全面見解，查看此財務健康報告。</li>
<li>檢查 Vista Gold 的過往業績報告，以瞭解其在過去幾年的表現。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/67ea27c1-9857-411a-b06d-a422d7c3fae9/chart/financial-position-analysis"/></p>
<p>NYSEAM:VGZ Financial Position Analysis as at Apr 2025</p>
<div class="lb-trans"><p>截至 2025 年 4 月的 NYSEAM:VGZ 財務狀況分析</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用機會</h2>
</div><ul>
<li>Dive into all 761 of the US Penny Stocks we have identified here.</li>
<li>Interested In Other Possibilities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入瞭解我們在這裏識別的 761 只美國便士股票。</li>
<li>對其他可能性感興趣？今天最好的人工智能股票可能不止於像 Nvidia 和 Microsoft 這樣的巨頭。通過這 24 家專注於人工智能的小型公司，尋找下一個重大機會，這些公司在機器學習、自動化和數據智能方面的早期創新具有強大的增長潛力，可能為您的退休提供資金。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們基於歷史數據和分析師預測提供評論，僅使用無偏見的方法，我們的文章不構成財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><p>If you're looking to trade QuantaSing Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 QuantaSing Group，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受無隱藏費用，無賬户最低限額，外匯轉換率低至 0.03%，遠遠優於大多數經紀商提供的服務。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>贊助內容</p>
</div>

3 只市值超過 1 億美元的有潛力的便士股